Results 21 to 30 of about 4,857 (187)
Cannabinoid type 1 and type 2 receptor antagonists prevent attenuation of serotonin-induced reflex apneas by dronabinol in Sprague-Dawley rats. [PDF]
The prevalence of obstructive sleep apnea (OSA) in Americans is 9% and increasing. Increased afferent vagal activation may predispose to OSA by reducing upper airway muscle activation/patency and disrupting respiratory rhythmogenesis.
Michael W Calik, David W Carley
doaj +1 more source
Acetylcholinesterase Inhibitory Activity of Standardized Cannabinoids-rich Fractions [PDF]
Background: Since cannabis has been legally allowed for medicinal purposes in many countries, it has become the most interesting issue, particularly in neurologic disorders, such as Alzheimer’s disease (AD).
Wiwit Suttithumsatid +4 more
doaj
Unexpected improvement of hyperhidrosis with cannabidiol [PDF]
Hyperhidrosis is characterized by excessive sweating and it affects almost 5% of the population. The affected age group is wide, and it can affect from children to elderlies. There are two types of hyperhidrosis: generalized and focal.
Rubens Pitliuk +2 more
doaj +1 more source
Fetal Cannabinoid Syndrome: Behavioral and Brain Alterations of the Offspring Exposed to Dronabinol during Gestation and Lactation [PDF]
Navarro D +3 more
europepmc +2 more sources
Cannabinoids in treatment of obstructive sleep apnea syndrome
Introduction and objective Obstructive sleep apnea syndrome (OSAS) is becoming increasingly more prevalent in the general population. Its negative impact on the cardiovascular system and patients’ non-compliance to validated treatment options is a ...
Paulina Maria Szot, Antoni Krzeski
doaj +1 more source
Background: Overriding the differentiation blockage in acute myeloid leukemia (AML) is the most successful mode-of-action in leukemia therapy – now curing the vast majority of patients with acute promyelocytic leukemia (APL) using all-trans retinoic acid
K.M. Kampa-Schittenhelm +15 more
doaj +1 more source
Hyperhidrosis can significantly curtail patient quality of life, from debilitating physical symptoms to social stigmatization and reduced life opportunities.
Till Kaemmerer +4 more
doaj +1 more source
Cannabis therapy in neurological disorders: Recent advances and perspectives [PDF]
Both phytocannabinoids (Δ9-tetrahydrocannabinol, cannabidiol) and synthetic derivatives (nabilone, dronabinol) showed therapeutic benefits in some neurological disorders.
Alexandru Mandici +2 more
doaj +1 more source
The hypothesis of this study was that we can modify the essential oil (EO) profile of hemp (Cannabis sativa L.) and obtain fractions with differential composition and antimicrobial activity.
Valtcho D. Zheljazkov +5 more
doaj +1 more source

